Botulinum Toxin Therapy in Congenital Blepharospasm
Botulinum toxin injections are the treatment of choice for the management of essential blepharospasm in adults. No cases of congenital blepharospasm have been described in the literature so far, and no cases of botulinum toxin injection in an infant have been reported. A 4-week-old girl was referred...
| Published in: | Case Reports in Ophthalmology |
|---|---|
| Main Author: | Bettina Wabbels |
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2014-12-01
|
| Subjects: | |
| Online Access: | http://www.karger.com/Article/FullText/370143 |
Similar Items
Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm
by: Thomas Ravi, et al.
Published: (1993-01-01)
by: Thomas Ravi, et al.
Published: (1993-01-01)
Asymmetric Blepharospasm Treated with Botulinum Toxin-A: Case Report
by: Gözde BARAN, et al.
Published: (2019-01-01)
by: Gözde BARAN, et al.
Published: (2019-01-01)
Effective treatment of hemifacial spasm and blepharospasm with botulinum toxin type A in Songklanagarind Hospital
by: S Setthawatcharawanich, et al.
Published: (2007-06-01)
by: S Setthawatcharawanich, et al.
Published: (2007-06-01)
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
by: Travis J.W. Hassell, et al.
Published: (2020-04-01)
by: Travis J.W. Hassell, et al.
Published: (2020-04-01)
Preseptal and Pretarsal Botulinum Toxin Injection in Hemifacial Spasm and Blepharospasm: A 10-Year Comparative Study
by: Teekaput C, et al.
Published: (2023-01-01)
by: Teekaput C, et al.
Published: (2023-01-01)
Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A—30 Years of Experience in a Tertiary Care Center
by: Bettina Wabbels, et al.
Published: (2022-02-01)
by: Bettina Wabbels, et al.
Published: (2022-02-01)
Frequency of Hemorrhagic Side Effects of Botulinum Neurotoxin Treatment in Patients with Blepharospasm and Hemifacial Spasm on Antithrombotic Medication
by: Fiona Carolin Wenninger, et al.
Published: (2022-11-01)
by: Fiona Carolin Wenninger, et al.
Published: (2022-11-01)
Functional blindness: Blepharospasm with apraxia of eyelid opening
by: Titap Yazicioglu
Published: (2020-01-01)
by: Titap Yazicioglu
Published: (2020-01-01)
Budget Impact Analysis of Botulinum Toxin Type A for Patients with Severe Blepharospasm in Thailand
by: Hirunwiwatkul P, et al.
Published: (2025-10-01)
by: Hirunwiwatkul P, et al.
Published: (2025-10-01)
Botulinum Toxin in Oculoplasty: An Overview
by: Sindhuja Murugesan, et al.
Published: (2024-09-01)
by: Sindhuja Murugesan, et al.
Published: (2024-09-01)
Sensory Trick Frames: A New Device for Blepharospasm Patients
by: Daniele Lorenzano, et al.
Published: (2019-01-01)
by: Daniele Lorenzano, et al.
Published: (2019-01-01)
Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series
by: Jonathan Sung, et al.
Published: (2022-08-01)
by: Jonathan Sung, et al.
Published: (2022-08-01)
Patient Characteristics and Real-World Use of Botulinum Toxins for the Treatment of Cervical Dystonia, Blepharospasm, and Hemifacial Spasm
by: Michael A. Hast, et al.
Published: (2024-08-01)
by: Michael A. Hast, et al.
Published: (2024-08-01)
Botulinum toxin A in the treatment of blepharospasm: a 10-year experience Toxina botulínica tipo A no tratamento do blefaroespasmo: experiência de 10 anos de utilização
by: Laura Silveira-Moriyama, et al.
Published: (2005-06-01)
by: Laura Silveira-Moriyama, et al.
Published: (2005-06-01)
The Effect of Botulinum Toxin Type A in Patients with Essential Blepharospasm
by: Klara Gaćina, et al.
Published: (2022-01-01)
by: Klara Gaćina, et al.
Published: (2022-01-01)
Blepharospasm with elevated anti-acetylcholine receptor antibody titer
by: Min Tang, et al.
by: Min Tang, et al.
Surgical Aspect of Blepharospasm Treatment: a Case Report
by: Kristijan Dinjar, et al.
Published: (2020-01-01)
by: Kristijan Dinjar, et al.
Published: (2020-01-01)
FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia
by: Lauren L. Spiegel, et al.
Published: (2020-05-01)
by: Lauren L. Spiegel, et al.
Published: (2020-05-01)
Use of botulinum toxin in the management of dystonia in Parkinson’s disease
by: Charenya Anandan, et al.
Published: (2024-04-01)
by: Charenya Anandan, et al.
Published: (2024-04-01)
Specificity of using botulinic toxin type A for blepharospasm treatment
by: A. R. Artemenko, et al.
Published: (2020-01-01)
by: A. R. Artemenko, et al.
Published: (2020-01-01)
Use of Botulinum Neurotoxin in Ophthalmology
by: Emel Başar, et al.
Published: (2016-12-01)
by: Emel Başar, et al.
Published: (2016-12-01)
Five decades of the use of botulinum toxin in ophthalmology
by: Anna Leszczynska, et al.
Published: (2024-02-01)
by: Anna Leszczynska, et al.
Published: (2024-02-01)
Therapeutic Approach to Botulinum Injections for Hemifacial Spasm, Synkinesis and Blepharospasm
by: Gilad Yahalom, et al.
Published: (2022-05-01)
by: Gilad Yahalom, et al.
Published: (2022-05-01)
Topography of the Corrugator Supercilii Muscle Relative to the Eyebrow and Its Clinical Application in Botulinum Toxin Injections
by: Hyun Jin Shin, et al.
Published: (2025-02-01)
by: Hyun Jin Shin, et al.
Published: (2025-02-01)
Correlation between blepharospasm and psychological diseases: the anxiety, depression and sleep disorder study
by: Hui-Na Zhang, et al.
Published: (2024-11-01)
by: Hui-Na Zhang, et al.
Published: (2024-11-01)
Benign essential blepharospasm: epidemiology, clinical manifestations, pathophysiology, botulinum toxin therapy
by: Z. A. Zalyalova
Published: (2021-02-01)
by: Z. A. Zalyalova
Published: (2021-02-01)
Blepharospasm Patients after Botulinum Toxin – Sleep Approach
by: Silvia Lestingi, et al.
Published: (2023-03-01)
by: Silvia Lestingi, et al.
Published: (2023-03-01)
Botulinum Toxin Physiology in Focal Hand and Cranial Dystonia
by: Barbara Illowsky Karp
Published: (2012-11-01)
by: Barbara Illowsky Karp
Published: (2012-11-01)
Tear film lipid layer thickness and blink dynamics in patients with blepharospasm
by: Ji-Sun Paik, et al.
Published: (2025-01-01)
by: Ji-Sun Paik, et al.
Published: (2025-01-01)
Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II
by: Ruth Kent, et al.
Published: (2021-07-01)
by: Ruth Kent, et al.
Published: (2021-07-01)
Comparative analysis of onabotulinum toxin type-A injection techniques in older adults with blepharospasm: a retrospective cohort study
by: Turan Poyraz, et al.
Published: (2025-10-01)
by: Turan Poyraz, et al.
Published: (2025-10-01)
Toxina botulínica no blefaroespasmo, no espasmo hemifacial e na distonia cervical: resultados em 33 pacientes Botulinum toxin in blepharospasm, hemifacial spasm and cervical dystonia: results in 33 patients
by: Sérgio Ap. Novis, et al.
Published: (1995-09-01)
by: Sérgio Ap. Novis, et al.
Published: (1995-09-01)
Recombinant botulinum toxin as a new stage in the development of botulinum toxin therapy. Possibilities and perspectives of use in neurological practice
by: R. K. Shikhkerimov, et al.
Published: (2022-12-01)
by: R. K. Shikhkerimov, et al.
Published: (2022-12-01)
Sexual dysfunction in cervical dystonia and blepharospasm
by: Marek M, et al.
Published: (2018-10-01)
by: Marek M, et al.
Published: (2018-10-01)
Comprehensive Korean Medicine Treatment for Benign Essential Blepharospasm in a Patient Responding Poorly to Botulinum Toxin Treatment
by: Seojung Ha, et al.
Published: (2022-02-01)
by: Seojung Ha, et al.
Published: (2022-02-01)
Comparative study of brain activity and functional connectivity in blepharospasm and blepharospasm-oromandibular dystonia
by: Yanying Wang, et al.
Published: (2025-07-01)
by: Yanying Wang, et al.
Published: (2025-07-01)
Applications, impacts and consequences of botulinum toxin usage in medicine
by: Weronika Kiełt, et al.
Published: (2024-10-01)
by: Weronika Kiełt, et al.
Published: (2024-10-01)
A Case with Improvement of Blepharospasm by Zolpidem
by: Munkyung Sunwoo, et al.
Published: (2011-05-01)
by: Munkyung Sunwoo, et al.
Published: (2011-05-01)
BOTULINUM TOXIN FOR THE TREATMENT OF CHRONIC HEADACHE
by: L. B. Zavaliy, et al.
Published: (2016-03-01)
by: L. B. Zavaliy, et al.
Published: (2016-03-01)
The Use of Botulinum Toxin in Medicine: Safety and Efficacy Based on the Latest Research
by: Anna Jaremek, et al.
Published: (2023-08-01)
by: Anna Jaremek, et al.
Published: (2023-08-01)
Similar Items
-
Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm
by: Thomas Ravi, et al.
Published: (1993-01-01) -
Asymmetric Blepharospasm Treated with Botulinum Toxin-A: Case Report
by: Gözde BARAN, et al.
Published: (2019-01-01) -
Effective treatment of hemifacial spasm and blepharospasm with botulinum toxin type A in Songklanagarind Hospital
by: S Setthawatcharawanich, et al.
Published: (2007-06-01) -
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
by: Travis J.W. Hassell, et al.
Published: (2020-04-01) -
Preseptal and Pretarsal Botulinum Toxin Injection in Hemifacial Spasm and Blepharospasm: A 10-Year Comparative Study
by: Teekaput C, et al.
Published: (2023-01-01)
